Understanding hallucinations in probable Alzheimer's disease: Very low prevalence rates in a tertiary memory clinic

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Mascha M J LinszenIris E C Sommer

Abstract

Averaging at 13.4%, current literature reports widely varying prevalence rates of hallucinations in patients with probable Alzheimer's disease (AD), and is still inconclusive on contributive factors to hallucinations in AD. This study assessed prevalence, associated factors and clinical characteristics of hallucinations in 1227 patients with probable AD, derived from a tertiary memory clinic specialized in early diagnosis of dementia. Hallucinations were assessed with the Neuropsychiatric Inventory. Hallucination prevalence was very low, with only 4.5% (n = 55/1227) affected patients. Hallucinations were mostly visual (n = 40/55) or auditory (n = 12/55). Comorbid delusions were present in over one-third of cases (n = 23/55).Hallucinations were associated with increased dementia severity, neuropsychiatric symptoms, and a lifetime history of hallucination-evoking disease (such as depression and sensory impairment), but not with age or gender. In the largest sample thus far, we report a low prevalence of hallucinations in probable AD patients, comparable to rates in non-demented elderly. Our results suggest that hallucinations are uncommon in early stage AD. Clinicians that encounter hallucinations in patients with early AD should...Continue Reading

References

Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Sep 1, 1996·Journal of the American Geriatrics Society·B C Jost, G T Grossberg
Sep 5, 2003·Psychosomatics·Medhat M Bassiony, Constantine G Lyketsos
Feb 14, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Robert PerneczkyAlexander Kurz
Jul 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Romina MizrahiRobert G Robinson
Dec 2, 2010·BMC Geriatrics·Rianne van der LindeUNKNOWN Medical Research Council Cognitive Function and Ageing Study
Aug 28, 2012·Dementia and Geriatric Cognitive Disorders·Lauren P WadsworthGad A Marshall
Mar 13, 2014·Journal of Alzheimer's Disease : JAD·Wiesje M van der FlierPhilip Scheltens
Jun 18, 2014·Schizophrenia Bulletin·Louise C JohnsFrank Larøi
Jul 1, 2014·The Lancet. Psychiatry·Iris E Sommer, René S Kahn
Feb 27, 2017·Neuroscience and Biobehavioral Reviews·Mohamad El HajPascal Antoine
Mar 13, 2018·Current Opinion in Psychiatry·Iris E SommerKenneth Hugdahl

❮ Previous
Next ❯

Software Mentioned

R
PropCIs
SPSS Statistics

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

International Journal of Geriatric Psychiatry
Medhat M BassionyConstantine G Lyketsos
European Psychiatry : the Journal of the Association of European Psychiatrists
Reinhard HeunUrsula Ptok
American Journal of Alzheimer's Disease and Other Dementias
Maria do Céu FerreiraAna Sofia Costa
© 2022 Meta ULC. All rights reserved